02242010

 

Excerpta Medica becomes a preferred partner for Astellas Pharma Inc.

02/24/2010

 

Astellas Pharma Inc. has chosen Excerpta Medica to be a partner for scientific and strategic communications (publication) planning and delivery for their novel oral anti-hyperglycemic agent currently under development in Japan, Asia, the USA, and Europe.

NEWS ITEMS

03/04/2013
Excerpta Medica US is going places!

 

05/30/2012
Excerpta Medica publication staff gain CMPP™ credentials

 

04/23/2012
Visit Excerpta Medica at the ISMPP 2012 Annual Meeting

 

04/13/2012
The key to success in educational initiatives?

 

12/01/2011
PME certification awarded to Excerpta Medica

11/08/2011
Former Director Pierre Vinken dies at 83

10/06/2011
Excerpta Medica joins the Healthcare Communications Association

09/12/2011
Fusing medical communication & digital expertise

05/31/2011
Excerpta Medica growing in the USA

03/24/2011
Excerpta Medica recognized as GPP thought leader by Pharmaceutical Marketing Europe

03/18/2011
Excerpta Medica joins Omincom to support Red Cross in Japan earthquake/tsunami relief efforts

03/02/2011
Important update: Excerpta Medica Amsterdam, Bridgewater, and London

01/05/2011
Excerpta Medica – developing ability, maximizing delivery

11/04/2010
Just Published: cutting edge medical content by Excerpta Medica and univadis®

10/07/2010
Excerpta Medica Joins Adelphi Worldwide

08/30/2010
Excerpta Medica at EASD Stockholm

07/01/2010
Excerpta Medica launches new eCME accredited Pain Education website

06/23/2010
Excerpta Medica recognized as Marketing Thought Leader by Pharmaceutical Marketing Europe

06/10/2010
Excerpta Medica – growing, evolving, meeting client demands

04/26/2010
Excerpta Medica: an international company demonstrating global capabilities

04/19/2010
EM embraces social media to reach physicians

02/10/2010
EACCME grants second accreditation for Excerpta Medica e-learning course

02/24/2010
Excerpta Medica becomes a preferred partner for Astellas Pharma Inc.

01/20/2010
Sally-Anne Robinson joins the Excerpta Medica Business Development Group